Study variable | Did not complete treatment | Completed treatment | P-value | ||
---|---|---|---|---|---|
nL | Response to variable | nC | Response to variable | ||
Age: n (%) | 120 | 876 | |||
< 40 year | 79 (65.8) | 534 (61.0) | 0.31a | ||
≥ 40 year | 41 (34.2) | 342 (39.0) | |||
Gender: n (%) | 120 | 876 | 0.20a | ||
Male | 65 (54.2) | 417 (47.6) | |||
Female | 55 (45.8) | 459 (52.4) | |||
Marital Status: n (%) | 120 | 876 | 0.46a | ||
Single | 18(15.0) | 107(12.2) | |||
Married | 102(85.0) | 769(87.8) | |||
HCV genotype n (%) | 10 | 91 | 0.85 b | ||
Genotype 1 | 0 (0) | 1 (1.1) | |||
Genotype 2 | 1 (10) | 3 (3.3) | |||
Genotype 3 | 9 (90.0) | 86 (94.5) | |||
Genotype 4 | 0 (0) | 1 (1.1) | |||
Viral load in IU/mL(median(IQR)) | 16 | 594,217(16,481–29,445,155) | 125 | 508,551(493–79,121,294) | 0.30 c |
ALT in U/L(median(IQR)) | 108 | 79.5(16–957) | 796 | 72(11–781) | 0.45c |
AST in U/L (median(IQR)) | 21 | 69(23–230) | 151 | 46(14–508) | 0.03c |
Bilirubin in mg/dL(mean ± SD) | 82 | 0.99 ± 0.44 | 553 | 0.89 ± 0.40 | 0.05d |
Alkaline Phosphatase in U/L (mean ± SD) | 82 | 218.8 ± 77.8 | 535 | 207.4 ± 98.7 | 0.31d |
Albumin in g/dL (mean ± SD) | 23 | 4.3 ± 0.4 | 170 | 4.2 ± 0.6 | 0.32d |
Alpha Fetoprotein in ng/mL (median(IQR)) | 6 | 2.18(0.5–10.4) | 63 | 2.4(0.2–16.5) | 0.85c |
Hb in g/dL (mean ± SD) | 116 | 15.4 ± 14.2 | 826 | 13.7 ± 5.07 | 0.01d |
TLC in cell × 10 9 /L(mean ± SD) | 114 | 8.7 ± 8.8 | 805 | 7.5 ± 2.6 | 0.002d |